Bioline Rx Ltd ROCE
Quel est le ROCE de Bioline Rx Ltd?
Le ROCE de Bioline Rx Ltd est -37.20%
Quelle est la définition de ROCE?
Le retour sur capital utilisé (ROCE) est un ratio financier qui mesure la rentabilité d'une entreprise et l'efficacité avec laquelle son capital est utilisé.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE des entreprises dans Health Care secteur sur NASDAQ par rapport à Bioline Rx Ltd
Que fait Bioline Rx Ltd?
biolinerx is a clinical-stage, publicly-traded (nasdaq/ tase: blrx) biopharmaceutical development company based in modi'in, israel. this website or social media page (the “site”) of biolinerx ltd. (the “company”) may contain content posted by a third party or links to third party websites (the “content” or “third party content”). this content is provided solely for general informational purposes as a convenience to you and not as an endorsement by the company of the content. it does not constitute a recommendation or solicitation to purchase or sell any security or make any other type of investment or investment decision. the company is not responsible for this content and does not make any representations as to the subject matter, accuracy, completeness or timeliness or the content. if you decide to access linked third party websites, you do so at your own risk. there is no warranty of any kind, express or implied, regarding the content, including without limitation any warranty of m
Entreprises avec roce similaire à Bioline Rx Ltd
- agilon health, inc a ROCE de -37.41%
- Kura Oncology Inc a ROCE de -37.40%
- RM2 International S.A a ROCE de -37.39%
- Penbar Capital Ltd a ROCE de -37.35%
- Alector a ROCE de -37.27%
- ReTo Eco-Solutions Inc a ROCE de -37.24%
- Bioline Rx Ltd a ROCE de -37.20%
- Atlas a ROCE de -37.14%
- Artelo Biosciences a ROCE de -37.09%
- Artelo Biosciences a ROCE de -37.09%
- Artelo Biosciences a ROCE de -37.09%
- DiaMedica Therapeutics a ROCE de -36.96%
- Cassiar Gold Corp a ROCE de -36.89%